Evidence map›Paper›PMID 33674305›Full record

ArticleScience advances2021

PD-L1

Ajitha Thanabalasuriar, Abby J Chiang, Christopher Morehouse, Margarita Camara, Shonda Hawkins, Ashley E Keller, Adem C Koksal, Carolina S Caceres, Aaron A Berlin, Nicholas Holoweckyj and 11 more

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. PD-L1Respiratory research · 2025
    Article
  3. CXCR4iScience · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Alveolar macrophage function is impaired following inhalation of berry e-cigarette vapor.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Frontiers in immunology · 2024
    Article
  14. Article
  15. PD-1/PD-L1 blockade is a potent adjuvant in treatment of Staphylococcus aureus osteomyelitis in mice.Molecular therapy : the journal of the American Society of Gene Therapy · 2023
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 5 institutions in 6 countries.

Ajitha ThanabalasuriarMicrobial Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.ORCID 0000-0001-6281-3013
Abby J ChiangDynamic Omics, Antibody Discovery and Protein Engineering (ADPE), R&D, AstraZeneca, Gaithersburg, MD, USA.
Christopher MorehouseMicrobial Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.ORCID 0000-0003-1883-9894
Margarita CamaraMicrobial Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.ORCID 0000-0002-3004-9775
Shonda HawkinsAnimal Sciences and Technologies, Clinical Pharmacology and Safety Sciences, AstraZeneca, Gaithersburg, MD, USA.ORCID 0000-0002-6946-8125
Ashley E KellerMicrobial Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Adem C KoksalDynamic Omics, Antibody Discovery and Protein Engineering (ADPE), R&D, AstraZeneca, Gaithersburg, MD, USA.ORCID 0000-0002-3163-7421
Carolina S CaceresMicrobial Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.ORCID 0000-0003-2686-765X
Aaron A BerlinRespiratory and Immunology, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.ORCID 0000-0002-4499-8074
Nicholas HoloweckyjResearch and Early Development, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA.
Virginia N TakahashiMicrobial Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Lily ChengResearch and Early Development, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA.ORCID 0000-0002-3056-1891
Melissa de Los ReyesResearch and Early Development, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA.ORCID 0000-0002-6055-0413
Mark PelletierMicrobial Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Andriani C PateraMicrobial Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Bret SellmanMicrobial Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.ORCID 0000-0002-1172-8799
Sonja HessDynamic Omics, Antibody Discovery and Protein Engineering (ADPE), R&D, AstraZeneca, Gaithersburg, MD, USA.ORCID 0000-0002-5904-9816
Marcello MarelliDynamic Omics, Antibody Discovery and Protein Engineering (ADPE), R&D, AstraZeneca, Gaithersburg, MD, USA.ORCID 0000-0001-7095-8263
Chelsea C BooDynamic Omics, Antibody Discovery and Protein Engineering (ADPE), R&D, AstraZeneca, Gaithersburg, MD, USA.
Taylor S CohenMicrobial Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Antonio DiGiandomenicoMicrobial Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA. antonio.digiandomenico@astrazeneca.com.ORCID 0000-0003-1745-647X
AstraZeneca (Australia) · AUAstraZeneca (Germany) · DEAstraZeneca (Netherlands) · NLAstraZeneca (Finland) · FIAstraZeneca (Switzerland) · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The underlying mechanisms contributing to injury-induced infection susceptibility remain poorly understood. Here, we describe a rapid increase in neutrophil cell numbers in the lungs following induction of thermal injury. These neutrophils expressed elevated levels of programmed death ligand 1 (PD-L1) and exhibited altered gene expression profiles indicative of a reparative population. Upon injury, neutrophils migrate from the bone marrow to the skin but transiently arrest in the lung vasculature. Arrested neutrophils interact with programmed cell death protein 1 (PD-1) on lung endothelial cells. A period of susceptibility to infection is linked to PD-L1

Identifiers

PMID33674305
PMCPMC7935370
OpenAlexW3133722772

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.